PP
DCPH

Paloma Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Paloma Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,138
Closed -$213K – 2354
2020
Q3 		$213K Buy
+4,138
New +$203K 0.01% 1715

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Paloma Partners's DCPH Position: Q4 2020 in Review

Paloma Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2020, closing a stake of 4,138 shares — an estimated $213K sold.

Paloma Partners first reported a position in DCPH in Q3 2020 and held it in 1 quarter. The position peaked at $213K in Q3 2020. 182 funds tracked by Wall St. Rank hold DCPH as of Q4 2020.

  • Paloma Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 4,138 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2020, an estimated $213K.
  • Paloma Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Paloma Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $213K in Q3 2020.
  • 182 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.